Inherited complement deficiency states and SLE.
D001803:Blood Transfusion; D003166:Complement Activating Enzymes / Q000172:deficiency; D003167:Complement Activation; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency; D015922:Complement C1q; D015923:Complement C1r; D003173:Complement C1s; D003175:Complement C2 / Q000172:deficiency / Q000235:genetics; D003181:Complement C4 / Q000172:deficiency; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000172:deficiency*; D003613:Danazol / Q000627:therapeutic use; D005802:Genes, MHC Class II; D006680:HLA Antigens / Q000235:genetics; D006684:HLA-DR Antigens; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000235:genetics* / Q000276:immunology*
D003174:Complement C1 Inactivator Proteins; D003175:Complement C2; D003181:Complement C4; D015938:Complement Membrane Attack Complex; D006680:HLA Antigens; D006684:HLA-DR Antigens; D015922:Complement C1q; D003165:Complement System Proteins; D003166:Complement Activating Enzymes; D015923:Complement C1r; D003173:Complement C1s; D003613:Danazol